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SUMMARY
A number of pathogens cause chronic infection in survivors of acute disease and this is believed to
be a common means of persistence, including for highly virulent agents. We present a model in
which transmission from chronically infected hosts causes chronic infection in naive individuals,
without causing acute disease – indeed ‘protecting’ against it. Thus the pathogen obtains the beneﬁt
of virulence (high transmission rate), but mitigates against the cost (high host mortality). Recent
ﬁndings suggest that rabbit haemorrhagic disease virus (RHDV), a highly contagious and virulent
pathogen, may also utilize this alternative, ‘avirulent ’, mode of transmission. The model may
resolve the paradox of how RHDV can be highly prevalent in some populations, in the absence of
mortality. Diﬀerences in host demography determine whether avirulent transmission prevents
large-scale mortality (as in most UK populations) or not. Other pathogens may exhibit similar
behaviour and the implications for emerging diseases in general are discussed.
INTRODUCTION
In the typical course of infection of a competent host,
the infecting pathogen multiplies and causes the host
to become infectious. The level of infection increases
until a point of crisis is reached, when either the host
dies, or develops immunity and infectiousness ceases.
However a number of pathogens are able to remain
active in the host even after immunity has developed,
causing a long-term chronic infection with the patho-
gen shed at reduced rates (e.g. Salmonella typhi,
Mycobacterium tuberculosis and M. bovis, hepatitis B
virus, herpes simplex virus). Such an infectious chronic
state can be lifelong. A number of models featuring
infectious chronic infection have been developed,
in which the outcome of a transmission event is deter-
mined by the status of the ‘recipient’ of infection, with
all infections of naive hosts being acute (e.g. [1, 2]).
However, the status of the source of infection may
also be important, with the quantity of pathogen shed
determining the type of infection (acute or chronic)
developed by the recipient. In the model presented
here, the nature of new infections depends upon the
status of the source of infection, not the recipient.
Thus the model has the novel feature that the infec-
tious agent has two modes of transmission that are
simultaneously in ‘competition’ for susceptibles. In
light of new evidence for an avirulent mode of trans-
mission of the highly virulent rabbit haemorrhagic
disease virus, we apply the model to examine the para-
dox of how a pathogen that causes huge mortality in
some populations apparently persists in others at high
prevalence in the absence of disease. Additionally we
examine the advantage to the pathogen of having two
phases of infection.
Rabbit haemorrhagic disease virus (RHDV) is a
highly virulent pathogen that kills up to 95% of
infected rabbits (Oryctolagus cuniculus) 48 h post-
infection [3–6]. Outbreaks killed 140 million farmed
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rabbits in China in 1984 [7], 64 million farmed rabbits
in Italy in 1986 [8] and 30 million wild rabbits in
Australia in just a few weeks following its release
in 1995 [6]. However, immunity to RHDV has been
found in the absence of signs of disease in both wild
and captive populations from a number of locations,
including the former Czechoslovakia, Switzerland,
Austria, Germany and Sweden [9–13]. Seroprevalence
was particularly high in the United Kingdom, with a
mean of 64% and a maximum of 100% [14, 15]. It
has been proposed that this immunity may be due
to a non-pathogenic strain of RHDV [10–14], such as
that isolated from a rabbitry in Italy in 1996 [9, 16].
However, despite extensive and intensive sampling
this non-pathogenic strain has not been found else-
where, and recent research by Moss et al. [17] has
suggested that the same virus can be responsible for
both large-scale mortality and also highly-prevalent
avirulent infection, found in the absence of mortality.
Moss et al. [17] used RT–PCR to test >40 serum
samples from healthy UK rabbits, both captive and
wild, from ﬁve locations, that showed no signs of dis-
ease, either at the time of sampling or in subsequent
weeks and months. Half of the samples contained
detectable levels of RHDV, but in no case was the
‘Italian’ non-pathogenic strain detected. Nucleotide
sequences were indistinguishable from those of patho-
genic RHDV by phylogenetic analysis of 527 nucleo-
tides that encode part of the outer region of the VP60
capsid protein. This region of the genome has been
used in most phylogenetic studies ofRHDV (e.g. [11]),
and contains signiﬁcant diﬀerences between patho-
genic RHDV and the ‘Italian’ non-pathogenic strain
[9, 16]. In all cases, sera that contained RHDV also
contained antibodies against the virus, suggesting that
long-term infection had occurred, despite a host im-
mune response. Consistent with this, Shien et al. [18]
reported that virus was detectable for at least 47
days (the end of the experiment) in survivors of acute
(experimental) infection. The aforementioned ﬁnd-
ing of very high seroprevalence (up to 100%) in the
absence of mortality strongly suggests that both infec-
tion and subsequent transmission can occur in the
absence of acute disease. Furthermore, RHDV was
detected in rabbit serum samples taken in the 1950s,
which implies that the virus has been circulating in the
United Kingdom for at least 40 years before it was
detected. This complements and extends the ﬁndings
of Rodak et al. [13] who reported the presence of anti-
RHDV antibodies in Czech rabbit sera collected in
1975, a decade before the discovery of RHDV.
There is a marked diﬀerence in the levels of virus in
acute and chronically infected rabbits, which may
explain the diﬀerent modes of transmission. In acute-
infected rabbits, RHDV is found at very high titres,
being detectable in liver homogenate even after 109-
fold dilution [5], and ﬂyspots can contain enough
RHDV to cause acute infection, indicating that it is
shed at high concentration [19]. In contrast, detection
of the virus in the sera of healthy rabbits required the
use of nested RT–PCR to enhance sensitivity [17], and
virus was found at low levels in survivors of experi-
mental infection [18]. Note that such low viral titres
are not incompatible with successful transmission
of RHDV: detection of the ‘Italian’ non-pathogenic
strain also requires enhanced-sensitivity techniques,
yet it was shown to be transmissible, and indeed it
persisted in a rabbitry for at least 2 years [9, 16].
The determinant of whether the initial infection
with RHDV results in acute disease or chronic infec-
tion may be the viral ‘dosage’ received – which may
vary by several orders of magnitude, considering the
evidence above. Following infection, virus replicates
at a rapidly accelerating rate. The antibody-mediated
immune response occurs 2–3 days post-infection [3]
and if this immune response succeeds in arresting viral
ampliﬁcation before a fatal amount of liver damage
occurs then the rabbit survives and develops chronic
infection, otherwise death results. We expect that the
time taken for fatal damage to occur will depend upon
the size of the initial viral inoculum, with acute infec-
tion resulting from a ‘large’ inoculum (received from
an acute-infected rabbit) enabling infection to pro-
gress rapidly, usually overwhelming the host before
antibodies have been produced in suﬃcient quantity
to control the infection. A smaller inoculum (from a
chronically infected rabbit) would allow more time for
the host immune system to respond before fatal liver
damage occurs. Thus the two phases of infection may
be simply a consequence of the kinetics of infection
and the host’s immune response, without requiring
any specialized ‘molecular machinery’ on the part of
the virus to eﬀect a ‘switch’ in behaviour. In general
support of this conjecture regarding inoculum-dosage-
dependent eﬀects, Timms et al. [20] showed experi-
mentallywithmalaria inmice that both disease severity
and rate of progression increased with the size of the
inoculum.
In this paper we use a modelling approach to ex-
amine the epidemiological consequences of the fol-
lowing hypothetical scenario, which is illustrated in
Figure 1. Acute RHDV infection is short-term, with
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high disease-associated mortality, is highly infectious
and causes acute infection upon transmission, due to
a high rate of viral shedding. Survivors of acute infec-
tion develop chronic infection, which is longer-term,
much less infectious and causes chronic infection
upon transmission, due to a low rate of viral shed-
ding. Susceptible rabbits that acquire RHDV from
a chronic-infected rabbit develop chronic infection
themselves, without experiencing the acute phase.
Chronic infection does not cause any disease-associ-
ated mortality.
We examine whether this model can explain the
intriguing situation in the United Kingdom, where
immunity to RHDV, in the absence of observable
disease, was found in all 68 of the wild rabbit popu-
lations sampled, usually at very high prevalence
(mean 64%, range 10–100%) [14, 15]. Furthermore,
in the United Kingdom, virulent RHDV has had little
impact, nationally, in terms of the number of popu-
lations aﬀected and the total number of rabbits that
died, despite scattered lethal outbreaks having oc-
curred in wild populations country-wide since 1994
[21; P. J. White unpublished observations]. It appears
that there may be herd immunity, due to chronic infec-
tion, protecting most UK wild rabbit populations.
Consistent with this, there is a geographical trend of
mean seroprevalence decreasing from north to south,
and it is in the south where the majority of lethal out-
breaks have occurred. Furthermore, most UK popu-
lations hadmuch higher seroprevalence thanmainland
European populations (where 12, 19 and 46% have
been reported [12, 22]), which may explain the much
lesser impact of RHDV in the United Kingdom com-
pared to other infected countries.
Can the model explain how RHDV may have
persisted in the United Kingdom, unnoticed, at high
prevalence, for decades before lethal outbreaks were
recorded from the 1990s? Can it explain why sero-
prevalence is so variable and has a trend of increas-
ing from south to north? Furthermore, can it explain
why the United Kingdom has had only a few lethal
outbreaks, whereas other countries have been aﬀected
much more severely? Finally, we examine how the
virus may beneﬁt from having two phases of infection.
MODEL ANALYSIS
Description
A ﬂow diagram representing the model is shown
in Figure 1, with parameters summarized in Table 1.
The equations are as follows,
H=S+A+C,
d=a+s+b,
r=axb,
dH
dt
=rH 1x
H
K
 
xaA,
dS
dt
=H ax
rH
K
 
x
S
H
( b1A+b2C )xbS,
dA
dt
=b1S
A
H
xdA,
dC
dt
=b2S
C
H
+sAxbC:
Population dynamics parameters were estimated
from published data [23–27], as described in Appen-
dix (a). The productivity rate (the product of the birth
rate and nestling survival rate) is density-dependent,
reﬂecting the ﬁndings of Myers et al. [25] and Thomp-
son [26]. They reported that the maximum produc-
tivity rate was double the rate at equilibrium, so we
take a=2b, for all values of b used in this paper.
Withinrabbitpopulations,RHDVisprobably trans-
mitted by direct contact [28], through the respiratory
route, since the virus can be detected in the airways
of infected rabbits, which rapidly infect cage-mates
and experimental infection can be caused by intra-
nasal inoculation [16, 28, 29]. Rabbits are a social
S
CA
β1A/H β2C/H
b b
b
α
σ
H a –
rH
K
Fig. 1. Flow diagram of the model. Susceptible rabbits (S)
may acquire acute infection from an acute-infected indi-
vidual (A) at rate b1, or chronic infection from a chronic-
infected individual (C) at rate b2. Rabbits with acute in-
fection are subject to the disease-induced death rate, a, and
those that recover, at rate s, develop chronic infection. All
individuals are subject to the natural death rate, b. There is
density dependence in the productivity of the population.
Parameter estimates are in Table 1.
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species, making the rate at which each individual con-
tacts others insensitive to changes in total population
size. Therefore we assume that the rate of disease
transmission will be frequency dependent, which is
supported by empirical studies [30, 31].
Acute infection typically lasts for 2 days, with
95% mortality amongst infected rabbits [3–6]. Thus
(a+s)=0.5 and a/(a+s)=0.95; so a=0.475; s=
0.025. In the model, chronic infection does not induce
mortality and since virus has always been found cir-
culating in the presence of antibodies [17] we postulate
that infectiousness is lifelong. Each phase has its
own basic reproductive ratio, R0, for the acute phase,
R0,A=b1/d and for the chronic, R0,C=b2/b [see Ap-
pendix (b)].
Equilibrium analysis
The model has three infected equilibria (Fig. 2), of the
form (H, A, C ) : (i) with chronic-phase-infected indivi-
duals only (K, 0, C*), (ii) ‘coexistence’ with both acute
and chronic individuals (H*, A*, C*) and (iii) host
extinction due to RHDV. The chronic-phase-only
equilibrium (K, 0, C*), is relevant where R0,C>1 (i.e.
b2>b), and stable where R0,A<R0,C. Due to competi-
tion for susceptibles, where the chronic phase has the
higher R0 it excludes the acute (see [32]). The converse
does not apply because chronic phase individuals
result from the recovery of acutes. Thus there is no
acute-phase-only equilibrium, but rather coexistence,
with both phases present, which is relevant where
R0,A>1 and R0,A>R0,C. At the threshold where co-
existence (H*, A*, C*) becomes relevant (R0,A=R0,C),
the chronic-phase-only equilibrium (K, 0, C*) be-
comes unstable [Appendix (c)], but remains relevant.
This means that, where R0,A>R0,C, the system may
be at (K, 0, C*) but this can be invaded by acute
Table 1. Parameter deﬁnitions and estimates. Rates are per capita per day
a Maximum productivity rate
(in this paper, a=2b for all values of b)
0.00578–0.0342
b Natural death rate 0.00289–0.0171
K Carrying capacity 100
a Disease-induced death rate
(due to acute infection)
0.475
s Rate of recovery from acute infection 0.025
d Rate of loss of acute-infected individuals 0.50289–0.5171
b1 Transmission parameter
(b1 : acute, b2 : chronic)
b1=0.936; b2=0.0239
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Fig. 2. R0 map, showing the eﬀects on equilibrium behaviour
of varying R0, A and R0, C, by changing b1 and b2, respect-
ively. There are four modes : uninfected (R0, A, R0, C<1) ;
chronic phase infection only (R0, C>1,R0, A<R0, C) ; coexist-
ence :
R0, A>1,R0, A>R0, C>
R0, A[rR0, A(b+s)xab(R0, Ax1)]
d[rR0, Axa(R0, Ax1)]
and host extinction:
R0, A>1,R0, A>
R0, A[rR0, A(b+s)xab(R0, Ax1)]
d[rR0, Axa(R0, Ax1)]
>R0, C :
The uninfected equilibrium is relevant for all values of
R0, A and R0, C. The chronic-phase-only infected equilibrium
(K, 0, C*), is relevant where R0, C>1 but between the hori-
zontal dashed line (R0, C=1) and the diagonal line (R0, A=
R0, C) it can be invaded by the acute phase,moving the system
to coexistence (H*, A*, C*) or host extinction. The co-
existence and host extinction equilibria can only occur
following introduction of acute infection. Notice that in
the region (labelled *) bounded by the three lines, R0, C=1,
H*=0 and the long-dashed line, the virus is able to persist
only because both phases are present : without the chronic
phase, the acute would cause host extinction, whilst the
chronic phase alone could not invade the population. Apart
from b1 and b2, which are varied, other parameter values are
as in Table 1, with population demographic parameters
corresponding to theUKmean, i.e. b=0.00862; a=0.01724;
d=0.50862.
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infection, moving the system to (H*, A*, C*) or host
extinction (see below).
Chronic infection does not cause disease-induced
mortality, so in the chronic-phase-only equilibrium,
the population is at carrying capacity. Where there is
coexistence, disease-induced mortality due to acute
infection depresses the population below carrying
capacity. Indeed, host extinction can occur if acute in-
fection is suﬃciently prevalent. The boundary for host
extinction occurs where H*=0, and in R0,AxR0,C
space it is relevant where R0,A>1 and R0,C>0.
Expressions for H* and the boundary H*=0 in
R0,AxR0,C space, respectively, are:
H=K 1x
a(bb1xdb2)( b1xd )
rb1[ b1(b+s)xdb2]
 
;
R0, C=
R0, A[rR0, A(b+s)xab(R0, Ax1)]
d[rR0, Axa(R0, Ax1)]
:
The likelihood of host extinction is greatly reduced by
the infectious chronic phase (Fig. 2). If R0,C=0 then
the model becomes SIR-type, and examination of
the horizontal axis of Figure 2 shows that infected
equilibrium is possible only for a small range of R0,A
values. Thus the presence of avirulent transmission
promotes the persistence of the virus, and indeed
the acute phase, by reducing the likelihood of host
extinction. Also, it is possible for the chronic phase to
persist due to the presence of the acute, when it alone
could not invade a naive population. Thus there is a
region of parameter space where neither phase alone
could persist in a population, but together they can
coexist (Fig. 2). Note that the size of the region of
coexistence is sensitive to the disease-induced mor-
tality rate, a, increasing as it declines. A pathogen less
virulent than RHDV – with a lower case-fatality rate
(the proportion of those with acute infection that die
of disease), and/or a longer time to death – can have a
much larger region of coexistence.
Since the R0s of the two phases are aﬀected diﬀer-
entially by the natural death rate, b, host population
dynamics can aﬀect the behaviour of the system,
determining which of the three infected equilibria are
stable. The death rate of acute-infected rabbits, d,
is insensitive to b (because a4b) ; whereas chronic-
phase individuals are lost only through natural death.
So R0,A is almost invariant, whereas R0,C is very vari-
able among populations with diﬀerent dynamics. Thus
each phase may dominate in some populations and
not others, leading us to ask the questions, ‘Can this
variation in R0,C explain the range of seroprevalence
recorded in the United Kingdom in the absence
of disease? ’, and, ‘Have most of the UK rabbit
populations, particularly those in the north, been pro-
tected by the chronic phase infection, in contrast to
European populations? ’
UK seroprevalence and estimation of transmission
parameters
The range of seroprevalence recorded in the absence
of disease in the United Kingdom (10–100%) [14, 15]
indicates that R0,C has markedly diﬀerent values in
diﬀerent populations. This large variability in sero-
prevalence between populations then leads us to ask,
‘Can diﬀerences in population dynamics explain this
range of seroprevalence, and if so then what pro-
portion of UK populations are likely to be protected
by endemic chronic-phase infection?’ We estimate b2
(the chronic phase transmission parameter) by assum-
ing that a population with typical UK population
demography will have seroprevalence at the mean UK
level (64%) due to chronic-phase infection only. Then
we examine if the range of seroprevalence recorded in
the United Kingdom can be explained by diﬀerences
in the natural death rate. A typical UK population has
natural death rate, b=0.00862 [see Appendix (a)], and
using the relationship b2=b/(1xseroprevalence) [see
Appendix (d)], we estimate b2=0.0239. What range of
seroprevalence can be explained by diﬀerences in the
natural death rate, b, due to population demography?
The range of b values estimated for UK rabbit popu-
lations is 0.00289–0.0171, predicting a range of
seroprevalence of 28–88%, which encompasses the
seroprevalence ﬁgures recorded for most of the UK
populations sampled (52 out of 68), and corresponds
to R0,C=1.40–8.26.
As usual in studies of emerging diseases ﬁeld data
on the course of an epidemic are limited. We estimate
the acute phase transmission parameter, b1, using
the following information. An outbreak occurred at
Dawlish Warren in Devon [21], shortly after the sero-
prevalence survey was performed [14, 15]. Although
this site was not sampled, six others in Devon were.
Their mean seroprevalence was 45%, with the value
for the site nearest to Dawlish Warren being 43%.
Since these estimates were similar, we assume they
were representative of Dawlish Warren, with the
chronic phase being endemic at 45% prevalence.
Hence we estimate b for Dawlish Warren to be 0.0131,
using the estimate of b2 (see above) and the relation-
ship, b2=b/(1xseroprevalence) [Appendix (d)]. The
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condition for invasion of the chronic-infected equi-
librium by the acute phase is b1>db2/b=0.936.
Although this is formally a minimum estimate of b1
we expect that it is close to the true value, given that
the majority of outbreaks have occurred in regions
with relatively low seroprevalence [33]. If b1 were
substantially greater than this estimate then we would
expect there to have been more fatal outbreaks else-
where in the United Kingdom, where mean sero-
prevalence is higher.
Using the estimates for b1 and b2, we examine the
equilibrium behaviour of the model over the UK
range of natural death rate, b (Fig. 3). The chronic-
phase-only equilibrium (K, 0, C*) is relevant over the
entire range of b values, and where b<db2/b1 (i.e.
R0,A<R0,C) it is the only relevant infected equilib-
rium, because the chronic phase excludes the acute.
Where b>db2/b1 (i.e. R0,A>R0,C), both chronic-
phase-only (K, 0, C*) and coexistence (H*, A*, C*)
equilibria are relevant. In the chronic-phase-only
equilibrium (K, 0, C*) the population size is at carry-
ing capacity and does not vary with the natural death
rate, b, whereas seroprevalence is sensitive to b,
declining as it increases. By contrast, in the coexistence
equilibrium (H*, A*, C*), the acute phase depresses
the population size below carrying capacity and H*
is highly sensitive to b ; with host extinction occurring
where
b>
db2
b1
x
rb1s
rb1xa(b1xd )
 
,
whereas seroprevalence is insensitive to b. If the
chronic phase is endemic in a population where b>
db2/b1 (i.e. R0,A>R0,C) then acute infection is able
to invade, with its introduction moving the system
from the chronic-phase-only equilibrium (K, 0, C*) to
the coexistence equilibrium (H*, A*, C*), or causing
host extinction. The behaviour of the model reﬂects
the sensitivity of the chronic phase – and insensitivity
of the acute phase – to b : as b varies across the range
0.00289–0.0171, the corresponding R0 ranges are:
R0,C : 1.40–8.26; R0,A : 1.80–1.86. The model predicts
that where a population is at the chronic-phase-only
(K, 0, C*) equilibrium, its seroprevalence indicates
whether acute infection is able to invade and whether
an invasion would lead to depression of the host popu-
lation, or its extinction (Fig. 3). The lethal outbreaks
of RHDV in the United Kingdom occurred where
seroprevalence was lowest [33], which is where we
suggest natural death rates are highest and thus the
chronic-phase-only equilibrium (K, 0, C*) is able to
be invaded by acute infection, because b>db2/b1.
Dynamics of acute- and chronic-phase infections
The foregoing equilibrium analysis highlights the cost
of acute phase infection, with its high disease-induced
death rate (a), which means that chronic infection is
required to prevent host extinction (except where R0,A
is very low) (Fig. 2). Now we consider the beneﬁt of
acute infection, which is its high transmission para-
meter (b1), leading to its rapid spread through a naive
population. Lipsitch and Nowak [34] showed that, if
a more virulent strain of virus has a higher transmis-
sion parameter than a less virulent one, then this may
confer a transient advantage in the invasion of a naive
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Fig. 3. Eﬀect on equilibrium host population size and
seroprevalence of varying the host natural death rate, b,
across the UK range. The vertical solid line indicates the
threshold b=db2/b1 (i.e. R0, A=R0, C). Where b<db2/b1 the
only relevant infected equilibrium is chronic-phase-only
(K, 0, C*) (which is relevant over the whole range of b
values). Where b>db2/b1 the coexistence equilibrium (H*,
A*, C*) is also relevant, and when the acute phase is present,
host extinction occurs where
b>
db2
b1
x
rb1s
rb1xa( b1xd )
 
,
to the right of the vertical dashed line. The heavy solid line
represents equilibrium population size (expressed as % of
carry capacity) when the acute phase is present. (Equilibrium
population size when only the chronic phase is present is
always 100% and so is not shown.) The other lines represent
seroprevalence, with the solid line indicating seroprevalence
in the chronic-phase-only (K, 0, C*) equilibrium and the
dashed line, seroprevalence in the coexistence equilibrium,
(H*, A*, C*). Since both the equilibrium population size
and seroprevalence are expressed as percentages, they use
the same vertical axis.
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(or growing) host population, even if the more viru-
lent strain has the lower R0 and so will be excluded at
equilibrium by the less virulent one. We examine the
dynamical behaviour of RHDV’s invasion of a naive
population and then go on to consider how awild-type
strain may be favoured over a hypothetical mutant
strain that causes only chronic infection.
Consider the introduction of a rabbit with acute
infection with wild-type RHDV (which causes both
phases of infection) into a naive population, at
(K, 0, 0). Provided R0,A>1 there will follow a rapid
epidemic that kills most rabbits, followed by a decline
in the prevalence of acute infection. Survivors, in
which the infection has entered the chronic phase,
reproduce, and the population begins to recover.
Transmission from these chronic phase rabbits recruits
susceptibles into the chronic phase, protecting them
from acute infection. The system tends towards one of
the infected equilibria : (K, 0, C*), (H*, A*, C*) or host
extinction, depending upon the relative values of R0,A
and R0,C as discussed above. An example of each out-
come is shown in Figure 4. Note that in the case of
Figure 4(a) the chronic (‘endemic’) mode of transmis-
sion ‘takes over’ from the initial acute (‘epidemic’)
transmission without any attenuation of the virus or
evolution of genetic resistance in the host. Despite its
R0 being lower than that of the chronic phase, resulting
in its ultimate exclusion, the acute phase’s higher
transmission parameter means that it spreads more
rapidly in a naive population. Taking the approach
of Lipsitch and Nowak [34], we deﬁne the variable
r, the ratio of the prevalences of the acute and
chronic phases of infection: r=A/C. The acute phase
is favoured when dr/dt is positive and the chronic
phase is favoured when it is negative. The expression
for dr/dt is,
dr
dt
=r
S
H
( b1xb2)xaxs(1+r)
 
:
The acute phase is favoured when b14b2 and the sus-
ceptible proportion (S/H) is high, which occurs in
a naive population or one that is growing rapidly
through the birth or immigration of new susceptible
individuals. As the virus spreads through the popu-
lation, S/H declines, the acute phase loses the ad-
vantage and declines in prevalence with respect to the
chronic.
Now we compare the transmission success in a
naive population of a wild-type virus (‘Strain 1’),
which causes both acute and chronic phases of
infection, with that of an attenuated mutant (‘Strain
2’) which causes only chronic infection. The chronic
phases of Strain 1 and Strain 2 have identical proper-
ties. The model is modiﬁed as follows:A is replaced by
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Fig. 4. Eﬀect of introducing a single acute-phase-infected
individual into naive populations with diﬀerent natural
death rates. Other parameter values are as in Table 1. In-
itially the population is in equilibrium (K, 0, 0), at carry-
ing capacity. (a) b<db2/b1 (b=0.00289; a=0.00578; d=
0.50289) : the acute phase is excluded by the chronic phase,
and the population returns to carrying capacity. (b) b>db2/
b1 (b=0.0135; a=0.0270; d=0.5135) : coexistence is estab-
lished between the acute and chronic phases and the
population is depressed below carrying capacity. (c) :
b>
db2
b1
x
rb1s
rb1xa(b1xd)
 
(b=00171;a=00342;d=05171),
the host population goes extinct ultimately, with both
phases coexisting until this moment. Note that the simula-
tion outputs (a) and (b) are for 5 years (model years are
360 days), whilst (c) is for 2 years. Also the vertical axis of
(c) has a diﬀerent scale.
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A1 ; C is replaced by C1 ; the expressions for dS/dt and
H are modiﬁed with the inclusion of C2 ; and the
equation for dC2/dt is added:
H=S+A1+C1+C2,
dS
dt
=H ax
rH
K
 
x
S
H
[ b1A1+b2(C1+C2)]xbS,
dC2
dt
=b2S
C2
H
xbC2:
To compare the transmission success of the two
strains, we deﬁne the variable rk, the ratio of the
prevalences of Strain 1 and Strain 2: r0=(A1+C1)=C2.
Strain 1 is favoured when drk/dt is positive and Strain
2 is favoured when it is negative. The expression for
drk/dt is,
dr0
dt
=xr0
S
H
( b1xb2)xa
 
,
where x=A1/(A1+C1), the proportion of Strain 1 pre-
valence represented by the acute phase.
Strain 1 is favoured by large x, and a large suscep-
tible proportion (S/H) when b14b2. When invading
a naive population (i.e. initial conditions A1=C2=1,
C1=0, S/Hy1), Strain 1 has the advantage when
(b1xb2)>a. As invasion proceeds, Strain 1’s advan-
tage declines, as both S/H and x decline. However,
even if the acute phase (A1) is excluded ultimately
(b1/d<b2/b), the prevalence of Strain 1 at equilibrium
is greater than Strain 2, even though only their
chronic phases (which have identical properties) are
present, because of the initial rapid spread of Strain 1,
via its acute phase (Fig. 5). Furthermore, where
b>db2/b1, Strain 2 is excluded by the acute phase of
Strain 1 (A1), but the chronic phase of Strain 1 (C1)
coexists (although at high natural death rates, host
extinction can occur).
DISCUSSION
Theoretical work has shown how pathogen virulence
can be adaptive, when it occurs as the result of a
trade-oﬀ between the transmissibility of the pathogen
and the lifetime of the infected host [35]. However,
highly virulent pathogens are prone to local extinc-
tion, and there are a number of strategies for per-
sistence. Some pathogens utilize alternative ‘reservoir ’
hosts, although none has been found for RHDV,
despite extensive testing [5, 36, 37]. Another strategy
is to induce a carrier state, in which survivors of
acute infection remain infected, shedding the patho-
gen at reduced rates. In other models featuring infec-
tious chronic infection the outcome of a transmission
event is determined by the status of the ‘recipient’ of
infection, with all infections of naive hosts being
acute (e.g. [1, 2]). In contrast, in the model presented
in this paper, the nature of new infections depends
upon the status of the source of infection, with its
rate of pathogen shedding, and hence the quantity of
pathogen transmitted, determining the type of infec-
tion (acute or chronic) developed by the recipient.
The model has the novel feature that the pathogen has
two modes of transmission that are simultaneously in
‘competition’ for susceptibles.
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Fig. 5. Equilibrium prevalences of Strain 1 (which has acute
and chronic phases) and Strain 2 (chronic phase only)
following introduction of one rabbit infected with Strain 1
(in the acute phase) and one rabbit infected with Strain 2
(chronic phase) into a naive population, plotted against
natural death rate, b. The vertical solid line indicates
the threshold b=db2/b1 (i.e. R0, A=R0, C). Where b<db2/b1
(i.e. R0, A<R0, C), the acute phase of Strain 1 is excluded at
equilibrium, leaving only the chronic phases of the two
strains. The chronic phases of both strains have identical
parameter values, but Strain 1 has higher prevalence due to
its more rapid initial spread via its acute phase. (If Strain 1 is
introduced in its chronic phase then both strains reach the
same, mean, prevalence.) Where b>db2/b1 (i.e.R0, A>R0, C),
Strain 2 is excluded by the acute phase of Strain 1, but the
chronic phase of Strain 1 is still present due to recovery from
acute infection. To the right of the vertical dashed line,
which indicates where
b=
db2
b1
x
rb1s
rb1xa( b1xd )
 
,
acute infection causes host extinction (although, math-
ematically, Strain 1 still has a prevalence).
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The model has the important asymmetry that
chronic infection can exclude acute, but not vice versa
(because survivors of acute infection develop chronic
infection). This facilitates persistence of the pathogen
at equilibrium, by reducing the likelihood of host
extinction. Thus the pathogen is able to enjoy the bene-
ﬁts of virulence, in terms of a high transmission rate,
but mitigate against the cost, in terms of high host
mortality. It is possible for the same pathogen to cause
outbreaks of great mortality and also to persist at
high prevalence in the absence of mortality, through
transmission of acute and chronic infections, respec-
tively.
To investigate the dynamics of infection with such a
pathogen, we applied the model to RHDV, following
the important new ﬁndings of Moss et al. [17], that
the same virus may cause both large-scale mortality,
and also avirulent infection at high prevalence in the
United Kingdom, where all wild rabbit populations
that were sampled had seropositive individuals, in
the absence of disease-associated mortality [14, 15].
This simple model can explain the very high mean and
large range of seroprevalence in the absence of mor-
tality that has been found in the United Kingdom,
and the limited impact of acute infection, following its
introduction from mainland Europe [33]. There may
be numerous factors underlying the high mean sero-
prevalence (64%) and large range (10–100%) in the
United Kingdom and the failure of RHDV to cause
mortality on the scale seen elsewhere, except in a few
cases [33]. Current data allow only the examination
of two possibilities : diﬀerences in contact rates within
populations, or diﬀerences in host demography. Both
of these could explain the diﬀerences in seroprevalence
due to chronic infection, but diﬀerences in contact
rates could not explain why some populations are
at risk of acute phase invasion and others are not.
Changing the contact rate does not aﬀect the ratio of
the R0s of the two phases of infection: with reference
to Figure 2, changes in contact rate move the system
along a straight line passing through the origin. Since
this line does not cross the boundary where R0,A=
R0,C, changes in contact rate cannot explain how the
behaviour of the system would vary amongst popu-
lations at (K, 0, C*), with some potentially suﬀering
mortality due to acute phase invasion, and others not.
Host demography can explain both the diﬀerences
in seroprevalence amongst populations in the United
Kingdom and why some populations are protected
from acute-phase-induced mortality, whilst others are
not. The diﬀerences in the infectious periods of the
acute and chronic phases mean that their basic re-
productive rates diﬀer markedly in sensitivity to host
population dynamics, with R0,A being almost invar-
iant and R0,C being highly variable. The UK range
of natural death rates, 0.00289–0.0171, corresponds
to R0,A range 1.80–1.86, and R0,C range 1.40–8.26.
Where a population is at the chronic-phase-only
(K, 0, C*) equilibrium, its seroprevalence indicates
whether it is at risk from acute-phase invasion, and
whether such an invasion would lead to depression of
the host population, or its extinction. This is because
seroprevalence in the chronic-phase-only (K, 0, C*)
equilibrium indicates host natural death rate, b, which
determines which phase of infection has the higher R0
and whether acute infection causes host extinction in
the coexistence equilibrium (Fig. 3). The north of the
United Kingdom has higher mean seroprevalence
and has had fewer lethal outbreaks of RHDV than the
south [33]. In the context of the model, this can be ex-
plained by lower productivity, therefore lower natural
death rates, in the north. In those populations, R0,A<
R0,C, so acute infection cannot invade the chronic-
phase-only equilibrium (K, 0, C*). In some UK popu-
lations, predominantly in the south, R0,A>R0,C,
making the chronic-phase-only equilibrium (K, 0, C*)
prone to invasion.
Host demography may explain not only diﬀerences
within the United Kingdom but also the diﬀerence
between (most of) the United Kingdom and the re-
gions of mainland Europe where RHDV has had a
major impact. In most of the United Kingdom, rela-
tively low natural death rates favour the chronic
phase, resulting in widespread, usually high, sero-
prevalence without mortality. In mainland Europe,
where RHDV has had a much more signiﬁcant im-
pact, recorded seroprevalences were much lower than
theUnitedKingdom,which, we suggest, reﬂects higher
productivity rates, due to a longer breeding season
[38] and lower nestling mortality. Thus R0,A>R0,C,
making the chronic-phase-only equilibrium (K, 0, C*)
prone to invasion. In fact, in parts of mainland
Europe, the chronic-phase-only equilibrium may not
be relevant due to high natural death rates resulting
in R0,C<1.
This analysis is based on equilibrium behaviour
of the model, but short-term dynamics also may be
important. Firstly, naive populations may suﬀer
signiﬁcant transient mortality due to the rapid spread
of acute infection, before recovering, partially or com-
pletely, as illustrated in Figure 4(a) and (b). Secondly,
seasonal population dynamics may be important
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in prompting disease re-emergence. Rabbit popu-
lations in most of the world are highly seasonal, due
to seasonal breeding with high fecundity and high
juvenile mortality. In the United Kingdom typically
there is a 3- to 4-fold increase in numbers from the
winter minimum to the mid-summer peak [24], and
‘peaks’ in Australia can be even higher.
The rapid appearance of susceptibles during the
breeding season would stimulate an increase in the
prevalence of acute infection (if it were present in
the population), with a consequent increase in mor-
tality, due to its transmission parameter being much
greater than that of the chronic phase. With reference
to Model Analysis section on page 670, above, an
increase in the susceptible proportion, S/H, causes
dr/dt to become positive. Thus in populations where
there is coexistence between acute and chronic infec-
tion, acute infection would be present throughout the
year, at low prevalence and so causing relatively little
mortality, except during (and just after) the breeding
season when its rapid spread causes large-scale, notice-
able mortality. Additionally, in some populations
where the chronic phase ultimately excludes the acute,
if acute infection were introduced from elsewhere at
this ‘vulnerable ’ time then there could be signiﬁcant
transient mortality before the acute phase is ex-
cluded. This latter scenario was a ﬁnding of our pre-
vious modelling work (which assumed that there
were distinct pathogenic and non-pathogenic strains
of RHDV, rather than acute and chronic phases of
infection caused by a single strain) [33]. In practice,
these two diﬀerent circumstances would be diﬃcult
to distinguish in the ﬁeld. Note that this ‘seasonal
re-emergence ’ can occur simply a consequence of
the transmission dynamics of the two phases, with-
out requiring any physiological change in the host
or virus, such as the virus in a chronically-infected
host ‘switching’ to acute infection. More detailed
analysis of seasonality is beyond the scope of this
paper.
RHDV is a good model system for obtaining new
insights into the physiological mechanisms and evolu-
tionary aspects of virulence, since the virus apparently
possesses both virulent and avirulent modes of beha-
viour. Several further studies are needed, including
extension of the work of Moss et al. [17] to use whole
genome sequences, but with a 7.5 kb genome [16, 18]
this is a substantial undertaking. Additionally there
needs to be more investigation of the physiological
interaction between RHDV and its host. Key assump-
tions of the model presented here are that chronic
infection is (i) infectious, (ii) causes chronic infection
upon transmission (due to low-level viral shedding)
and (iii) lasts for life (or at least a long period).
Although the observational evidence is strong, these
assumptions need to be conﬁrmed by experimental
studies. To date, the eﬀect of low-dose inoculation
with RHDV has not been studied, with laboratory
studies using high doses of RHDV (typically 103–106
LD50 [3, 18, 37]), to ensure that (acute) infection
occurs.
More generally, the mechanism of infectious
chronic infection may be employed by other patho-
gens that persist at relatively high prevalence in their
host species despite their potential virulence, such as
M. bovis in badgers. A number of pathogens that
cause chronic infection are able to ‘switch’ between a
non-infectious latent state and an ‘active ’ infectious
state, when conditions may be more favourable to
transmission. Latency is amechanism bywhich patho-
gens causing (re-)emerging diseases are able to persist,
unnoticed, in between epidemic outbreaks, sometimes
for long periods. In the case of RHDV it is not known
if an analogous ‘activation’ of chronic infection may
occur, with bouts of increased viral shedding causing
acute (rather than chronic) infections upon trans-
mission. (Indeed we have discussed how disease re-
emergence could occur simply as a result of seasonal
host population dynamics coupled with coexistence
between acute and chronic infection, without requir-
ing such a ‘switch’ in the behaviour of the virus within
the chronically infected host.) However, such a mech-
anismwould allowRHDV – and other virulent patho-
gens whose ‘ latent’ state may actually be infectious
and cause chronic infection upon transmission – to
spread ‘silently ’, without causing apparent disease.
This would increase the likelihood of disease
(re-)emergence because there would be more individ-
uals with chronic infection, which may ‘activate ’ in a
stochastic event (perhaps due to immunosuppression
caused by the stress of crowding or reproduction or
another disease), and begin shedding virus at higher
levels, causing acute infections upon transmission and
initiating disease emergence.
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APPENDICES
(a) Estimation of natural death rate, b, from
population dynamics data
Published demographic studies commonly quote pro-
ductivity and adult mortality data. In order to
estimate the mean natural death rate for UK rabbit
populations, for use in a model without age structure,
the following approach is used. We consider a disease-
free, non-seasonal equilibrium population, at carrying
capacity, which therefore has a stable size and age-
structure. This population can be represented by an
age-structuredmodel and a non-age-structuredmodel.
In the age-structured model the population is divided
into juveniles, J, and adults, Ad, with the former
maturing at rate m. The rate at which new juveniles
enter the population is a function of the adult popula-
tion size, Ad, and productivity rate per adult, p, which
is the product of the birth rate per adult and nestling
survival. The daily death rate for juveniles is bJ and
for adults, bAd. In the non-age-structured model, the
population is of size R and the mean death rate, b, is
equal to the mean productivity rate at carrying
capacity, because in a stable population each birth
has a corresponding death.
The equations of the age-structured model are :
dJ
dt
=pAdx(bJ+m)J,
dAd
dt
=mJxbAdAd,
d(J+Ad)
dt
=pAdxbJJxbAdAd:
For the age-structured and non-age-structured
population models to be equivalent, total popu-
lation sizes must be equal (i.e. J+Ad=R) and the
‘total population’ death rates must be equal (i.e. bJJ
+bAdAd=bR). Solving the models at equilibrium
gives b=pm/(bAd+m).
UK birth rates of 14–22 young per adult female
per annum [27], combined with nestling survival in
the range 25–75% [24] gives a productivity range of
1.75–8.25 juveniles weaned per adult p.a., consistent
with Bell and Webb [23]. Adult annual mortality
ranges from 40–80%, giving bAd values in the range
0.00142–0.00447. The typical age of ﬁrst successful
breeding in the United Kingdom is 9 months (i.e. in
the following breeding season), which is 8 months
post-weaning, giving a daily maturation rate, m, of
0.00417. With the constraint that bJ>bAd, estimated
values of b are in the range 0.00289–0.0171. The
typical UK rabbit population has adult mortality of
60% per annum, with 5 juveniles weaned per adult
p.a., resulting in b=0.00862.
(b) Invasion of the uninfected equilibrium (K, 0, 0) :
calculation of R0 for each phase
The relevant Jacobian is,
J(K , 0, 0)=
xr xa 0
0 b1xd 0
0 s b2xb
2
64
3
75:
The eigenvalues satisfy,
l1=xr, l2=( b1xd ), l3=( b2xb):
The uninfected equilibrium is unstable (i.e. infection
can spread successfully in the population) if the
dominant eigenvalue does not have negative real
parts. For the uninfected equilibrium to be relevant,
l1 must be negative, so infection can invade if l2>1
(i.e. b1/d>1) and/or l3>1 (i.e. b2/b>1). Thus each
phase of infection can be considered to have its own
R0, where R0,A=b1/d and R0,C=b2/b.
(c) Invasion of the chronic-phase-only equilibrium
(K, 0, C*)
The relevant Jacobian is :
J(K , 0,C)=
xr xa 0
0
bb1
b2
xd 0
( b2xb)
2
b2
bxb2+s bxb2
2
666664
3
777775
:
The eigenvalues satisfy,
l1=xr, l2=
bb1
b2
xd
 
, l3=(bxb2),
l1 must be negative and a condition for the relevance
of (K, 0, C*) is that l3 is negative, so the only eigen-
value that may not have negative real parts is l2. Thus
acute infection can invade (K, 0, C*) where b1/d>
b2/b, i.e. where R0,A>R0,C. The system then moves to
(H*, A*, C*) or host extinction.
(d) Relationship between b2 and seroprevalence in
the chronic-phase-only equilibrium (K, 0, C*)
At (K, 0, C*), H*=S*+0+C*. Seroprevalence=
C*/H*=1x(S*/H*)=1x(b/b2). Rearranging, b2=
b/(1xseroprevalence).
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